Cargando…
Third doses of SARS-CoV-2 vaccines in immunosuppressed patients with inflammatory bowel disease
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511687/ https://www.ncbi.nlm.nih.gov/pubmed/34653395 http://dx.doi.org/10.1016/S2468-1253(21)00374-5 |
_version_ | 1784582819705520128 |
---|---|
author | Alexander, James L Selinger, Christian P Powell, Nick |
author_facet | Alexander, James L Selinger, Christian P Powell, Nick |
author_sort | Alexander, James L |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8511687 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-85116872021-10-13 Third doses of SARS-CoV-2 vaccines in immunosuppressed patients with inflammatory bowel disease Alexander, James L Selinger, Christian P Powell, Nick Lancet Gastroenterol Hepatol Correspondence Published by Elsevier Ltd. 2021-12 2021-10-13 /pmc/articles/PMC8511687/ /pubmed/34653395 http://dx.doi.org/10.1016/S2468-1253(21)00374-5 Text en Crown Copyright © 2021 Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Correspondence Alexander, James L Selinger, Christian P Powell, Nick Third doses of SARS-CoV-2 vaccines in immunosuppressed patients with inflammatory bowel disease |
title | Third doses of SARS-CoV-2 vaccines in immunosuppressed patients with inflammatory bowel disease |
title_full | Third doses of SARS-CoV-2 vaccines in immunosuppressed patients with inflammatory bowel disease |
title_fullStr | Third doses of SARS-CoV-2 vaccines in immunosuppressed patients with inflammatory bowel disease |
title_full_unstemmed | Third doses of SARS-CoV-2 vaccines in immunosuppressed patients with inflammatory bowel disease |
title_short | Third doses of SARS-CoV-2 vaccines in immunosuppressed patients with inflammatory bowel disease |
title_sort | third doses of sars-cov-2 vaccines in immunosuppressed patients with inflammatory bowel disease |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511687/ https://www.ncbi.nlm.nih.gov/pubmed/34653395 http://dx.doi.org/10.1016/S2468-1253(21)00374-5 |
work_keys_str_mv | AT alexanderjamesl thirddosesofsarscov2vaccinesinimmunosuppressedpatientswithinflammatoryboweldisease AT selingerchristianp thirddosesofsarscov2vaccinesinimmunosuppressedpatientswithinflammatoryboweldisease AT powellnick thirddosesofsarscov2vaccinesinimmunosuppressedpatientswithinflammatoryboweldisease AT thirddosesofsarscov2vaccinesinimmunosuppressedpatientswithinflammatoryboweldisease |